Vivos Therapeutics (VVOS) Minority Interest (2025 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Minority Interest of -$129000.0 for Q1 2026, down 115.0% quarter-over-quarter from -$60000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Minority Interest (2025 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Minority Interest for 2 consecutive years, with -$129000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest changed N/A year-over-year to -$129000.0; the TTM figure through Mar 2026 stood at -$129000.0 (changed N/A YoY), while the FY2025 annual figure was -$60000.0, changed N/A from the prior year.
- Minority Interest slipped to -$129000.0 in Q1 2026 per VVOS's latest filing, from -$60000.0 in the prior quarter.
- Across five years, Minority Interest topped out at -$60000.0 in Q4 2025 and bottomed at -$129000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -60,000.00 |